News for CollPlant Biotechnologies Ltd. (CLGN)

Operator: Greetings, and welcome to the CollPlant Biotechnologies Third Quarter 2024 Earnings Call. At this time all participants are in a listen-only mode.

Revenue (Q3 2024): $4,000 compared to $43,000 in Q3 2023.Revenue (Nine Months Ended September 30, 2024): $351,000 compared to $10.7 million in the same period

Nov 27, 2024 / 03:00PM GMTOperator Greetings, and welcome to the CollPlant Biotechnologies third quarter 2024 earnings call. (Operator Instructions) As a remind

CollPlant Biotechnologies Ltd (NASDAQ:CLGN) Q3 2024 Earnings Conference Call November 27, 2024 10:00 AM ETCompany ParticipantsDory Kurowski - LifeSci...

PR NewswireREHOVOT, Israel, Nov. 27, 2024 -Promising results obtained from the pre-clinical study with CollPlant's commercial sized rhCollagen-based regene

CollPlant Biotechnologies Ltd (CLGN) is set to release its Q3 2024 earnings on Nov 27, 2024. The consensus estimate for Q3 2024 revenue is $0.42 million, and th

According to a research report published by Exactitude Consultancy, Companies covered: Collplant Biotechnologies Ltd. (Israel), regenHU (Switzerland),...

CollPlant Biotechnologies Ltd. (NASDAQ:CLGN) Q2 2024 Earnings Call Transcript August 20, 2024CollPlant Biotechnologies Ltd. misses on earnings expectations.

Revenue: $249,000 for Q2 2024, compared to $10.2 million for Q2 2023.Cost of Revenues: $536,000 for Q2 2024, compared to $615,000 for Q2 2023.Gross Loss: $287,

CollPlant Biotechnologies Ltd. (NASDAQ:NASDAQ:CLGN) Q2 2024 Earnings Conference Call August 20, 2024 10:00 AM ETCompany ParticipantsDan Ferry - LifeSci...

Platelet-rich plasma (PRP) demand is being driven primarily by an increase in the number of patients suffering from orthopedic diseases, sports injuries, acute...

the first Israeli biotech company, where he served as Director of R&D from 1980 to 1987. During his managerial career Dr. Havron was directly involved in the multi-disciplinary development of many... | June 8, 2023

In this article you are going to find out whether hedge funds think Potbelly Corp (NASDAQ:PBPB) is a good investment right now.

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Feb. 11) 10X ...

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Feb. 9) Abbott ...